Results from a prospective registry of 18F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET
American Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.62347/iawb9145 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Steven Blinka und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, University of Washington 825 Eastlake Ave E, Seattle, WA 98109, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, University of Washington 825 Eastlake Ave E, Seattle, WA 98109, USA.
- Division of Clinical Research, Fred Hutchinson Cancer Center 1100 Fairview Ave N, Seattle, WA 98109, USA.
- Division of Hematology and Oncology, University of Pittsburgh, UPMC Hillman Cancer Center 5150 Centre Ave, Pittsburgh, PA 15232, USA.
- Department of Urology, University of Washington 1959 NE Pacific St, Seattle, WA 98195, USA.
- Division of Human Biology, Fred Hutchinson Cancer Center 1100 Fairview Ave N, Seattle, WA 98109, USA.
- Department of Radiology, University of Washington 1959 NE Pacific St, Seattle, WA 98195, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Blinka, S., Wong, R. L., Holt, S. K., Lo, E., Cheng, H. H., Conrad, N., Loesch, H., Toulouse, A. E., Lai, M., Hsieh, A. C., Grivas, P., Yezefski, T., Wright, J. L., Schweizer, M. T., Montgomery, R. B., Chen, D. L., Zeng, J., Lin, D. W., & Yu, E. Y. (2025). Results from a prospective registry of 18F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/iawb9145
Vancouver
Blinka S, Wong RL, Holt SK, Lo E, Cheng HH, Conrad N, et al. Results from a prospective registry of 18F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET. American Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.62347/iawb9145
BibTeX
@article{Blinka2025,
author = {Blinka, Steven and Wong, Risa L and Holt, Sarah K and Lo, Ethan and Cheng, Heather H and Conrad, Nathan and Loesch, Hannah and Toulouse, Andrea E and Lai, Michael and Hsieh, Andrew C and Grivas, Petros and Yezefski, Todd and Wright, Jonathan L and Schweizer, Michael T and Montgomery, Robert B and Chen, Delphine L and Zeng, Jing and Lin, Daniel W and Yu, Evan Y},
title = {Results from a prospective registry of 18F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.62347/iawb9145}
}
EUVIMED